FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

16208111000001109: Motens 2mg tablets (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Dec 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57143201000001114 Motens 2mg tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57143301000001117 Motens 2mg tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Motens 2mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Motens 2mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Motens 2mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Motens 2mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Motens 2mg tablets (Lexon (UK) Ltd) Is a Product containing precisely lacidipine 2 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Motens 2mg tablets (Lexon (UK) Ltd) Has active ingredient Lacidipine false Inferred relationship Existential restriction modifier
Motens 2mg tablets (Lexon (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Motens 2mg tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Motens 2mg tablets (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Motens 2mg tablets (Lexon (UK) Ltd) Has specific active ingredient Lacidipine true Inferred relationship Existential restriction modifier
Motens 2mg tablets (Lexon (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Motens 2mg tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Motens 2mg tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Motens 2mg tablets (Lexon (UK) Ltd) Is a Motens true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Motens 2mg tablets (Lexon (UK) Ltd) 28 tablet Has AMP True Motens 2mg tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start